Diploma PLC (LON:DPLM – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven analysts that are presently covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is GBX 5,634.29.
Several brokerages have recently issued reports on DPLM. Berenberg Bank reissued a “buy” rating and set a GBX 6,350 price target on shares of Diploma in a research report on Wednesday, November 19th. Deutsche Bank Aktiengesellschaft increased their price objective on Diploma from GBX 6,000 to GBX 6,200 and gave the company a “buy” rating in a report on Wednesday, January 14th. Finally, Peel Hunt reissued a “buy” rating and issued a GBX 6,150 price target on shares of Diploma in a research report on Friday, December 19th.
Check Out Our Latest Stock Report on DPLM
Diploma Stock Up 0.4%
Diploma (LON:DPLM – Get Free Report) last announced its quarterly earnings data on Monday, December 8th. The company reported GBX 176 earnings per share (EPS) for the quarter. Diploma had a net margin of 9.25% and a return on equity of 13.18%. On average, research analysts forecast that Diploma will post 163.7995512 EPS for the current year.
Insider Buying and Selling at Diploma
In other Diploma news, insider Wilson Ng acquired 410 shares of the company’s stock in a transaction on Friday, December 19th. The shares were bought at an average cost of GBX 5,369 per share, for a total transaction of £22,012.90. Also, insider Katie Bickerstaffe bought 352 shares of Diploma stock in a transaction dated Wednesday, January 14th. The stock was acquired at an average cost of GBX 5,645 per share, with a total value of £19,870.40. Insiders have bought 1,262 shares of company stock worth $6,995,830 in the last 90 days. Company insiders own 1.14% of the company’s stock.
About Diploma
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
See Also
- Five stocks we like better than Diploma
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- America’s 1776 happening again
- Unlocked: Elon Musk’s Next Big IPO
- Silver paying 20% dividend. Plus 68% share gains
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
